reclassify Marinol (dronabinol) from Schedule II to Schedule III

December 1998

The DEA is proposing to reclassify Marinol (dronabinol) from Schedule II to Schedule III.

Marinol has a low potential for abuse. Its slow onset doesn't produce the same high that people get from smoking marijuana.

Reclassifying Marinol might encourage more physicians to prescribe it...and reduce the demand for "medical marijuana."

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

a backlash from managed care against all the drug ads on TV, radio, magazines, etc
Infectious Diseases higher doses of amoxicillin for acute otitis media in children
Infectious Diseases new precautions about liver toxicity with the new quinolone, Trovan (trovafloxacin)
Interactions add carbamazepine (Tegretol) to the list of drugs that can interact with grapefruit juice
new drugs coming out for rheumatoid arthritis
Neurology & Pain new boxed warning about serious liver toxicity in patients taking Tasmar (tolcapone)
Women's Health which antiepileptic drugs interact with oral contraceptives (OCs)
Women's Health The National Cancer Institute is now offering a "Risk Disk"
Pulmicort Turbuhaler (budesonide) is now approved for ONCE daily dosing
Pediatrics Robi Comb, a small electronic comb to "zap" head lice
Pediatrics Versed (midazolam) now comes as an ORAL syrup
Pediatrics using secretin for autism
the first generic cyclosporine, SangCya (sang-see-ah)
Substance Use Disorder reclassify Marinol (dronabinol) from Schedule II to Schedule III
Substance Use Disorder people getting addicted to OTC stimulants
Substance Use Disorder first OTC drug abuse test that can be performed AT HOME
new question about whether it might cause nerve toxicity